Instability of the ecstasy market and a new kid on the block: mephedrone
Journal of Psychopharmacology September 8, 2010 Tibor M. Brunt, Anneke Poortman, Raymond J.m. Niesink et al. 217 citations
The ecstasy market in the Netherlands became unstable in 2009, with more than a 50% drop in tablets containing MDMA. A new substance, mephedrone, partially replaced MDMA in tablets sold as ecstasy, at doses between 96 and 155 mg. Based on reports from 70 regular ecstasy users, mephedrone produced enjoyable effects similar to other amphetamine-type stimulants, including MDMA, but unlike MDMA it induced strong cravings in most users. If the unstable market continues, mephedrone may substantially substitute for MDMA, raising health concerns.